Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 5-((1-methyl-3-indolyl)carbonyl)-4,5,6,7-tetrahydro-1h-benzimidazol
2. Methanone, (1-methyl-1h-indol-3-yl)(4,5,6,7-tetrahydro-1h-benzimidazol-5-yl)-, Monohydrochloride, (r)-
3. Nasea
4. Ramosetron Hydrochloride
5. Ym 060
6. Ym-060
7. Ym060
1. 132036-88-5
2. Ramosetron [inn]
3. (1-methylindol-3-yl)-[(5r)-4,5,6,7-tetrahydro-3h-benzimidazol-5-yl]methanone
4. 7zro0sc54y
5. Chembl1643895
6. Ramosetron (inn)
7. (r)-(1-methyl-1h-indol-3-yl)(4,5,6,7-tetrahydro-1h-benzo[d]imidazol-6-yl)methanone
8. Unii-7zro0sc54y
9. Nor-ym 060
10. Ramosetron [mi]
11. Ramosetron [who-dd]
12. Schembl16701
13. Gtpl2301
14. Dtxsid0043842
15. Chebi:135156
16. Zinc5116719
17. Bdbm50334454
18. (-)-(r)-1-methylindol-3-yl 4,5,6,7-tetrahydro-5-benzimidazolylketone
19. Akos015896003
20. Db09290
21. R-146
22. D08466
23. A806353
24. Ar-270/43507766
25. Q2979523
26. (-)-(r)-1-methylindol-3-yl-4,5,6,7-tetrahydro-5-benzimidazolyl Ketone
27. (-)-(r)-1-methylindol-3-yl-4,5,6,7-tetrahydro-5-benzimidazolyl Ketone.
28. (1-methyl-1h-indol-3-yl)(4,5,6,7-tetrahydro-1h-benzimidazol-6-yl)methanone
29. (1-methylindol-3-yl)-[(5r)-4,5,6,7-tetrahydro-3h-benzimidazol-5-yl]methanone.
30. (r)-(-)-5-[(1-methyl-3-indolyl)carbonyl]-4,5,6,7-tetrahydrobenzimidazole
31. (r)-5-[(1-methylindole-3-yl)carbonyl]-4,5,6,7-tetrahydro-1h-bezimidazole
32. Methanone, (1-methyl-1h-indol-3-yl)[(6r)-4,5,6,7-tetrahydro-1h-benzimidazol-6-yl]-
33. Methanone,(1-methyl-1h-indol-3-yl)[(6r)-4,5,6,7-tetrahydro-1h-benzimidazol-6-yl]-
Molecular Weight | 279.34 g/mol |
---|---|
Molecular Formula | C17H17N3O |
XLogP3 | 2.2 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 2 |
Exact Mass | 279.137162174 g/mol |
Monoisotopic Mass | 279.137162174 g/mol |
Topological Polar Surface Area | 50.7 Ų |
Heavy Atom Count | 21 |
Formal Charge | 0 |
Complexity | 413 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
For the treatment of nausea and vomiting and diarrhea-predominant irritable bowel syndrome in males.
Serotonin Antagonists
Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)
Antiemetics
Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)
Market Place
ABOUT THIS PAGE
15
PharmaCompass offers a list of Ramosetron API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ramosetron manufacturer or Ramosetron supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ramosetron manufacturer or Ramosetron supplier.
PharmaCompass also assists you with knowing the Ramosetron API Price utilized in the formulation of products. Ramosetron API Price is not always fixed or binding as the Ramosetron Price is obtained through a variety of data sources. The Ramosetron Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Nasea manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Nasea, including repackagers and relabelers. The FDA regulates Nasea manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Nasea API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Nasea manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Nasea supplier is an individual or a company that provides Nasea active pharmaceutical ingredient (API) or Nasea finished formulations upon request. The Nasea suppliers may include Nasea API manufacturers, exporters, distributors and traders.
click here to find a list of Nasea suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Nasea Drug Master File in Japan (Nasea JDMF) empowers Nasea API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Nasea JDMF during the approval evaluation for pharmaceutical products. At the time of Nasea JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Nasea suppliers with JDMF on PharmaCompass.
Nasea Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Nasea GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Nasea GMP manufacturer or Nasea GMP API supplier for your needs.
A Nasea CoA (Certificate of Analysis) is a formal document that attests to Nasea's compliance with Nasea specifications and serves as a tool for batch-level quality control.
Nasea CoA mostly includes findings from lab analyses of a specific batch. For each Nasea CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Nasea may be tested according to a variety of international standards, such as European Pharmacopoeia (Nasea EP), Nasea JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Nasea USP).